Wellcome Trust: R3 - RNA Readiness and Response (Abstract submission)

The focus of the scheme is on advancing ribonucleic acid (RNA)-based products, technologies and manufacturing capabilities to increase access to diverse biologics and sustainable pandemic responses. Proposals are required for work in one or more of the following thrust areas:

• Thrust Area 1: Establish the RNA 'Living' Biofoundry.
• Thrust Area 2: Increasing the diversity, number and pace of biologics development.
• Thrust Area 3: : Sustainable production under steady-state non-emergency conditions, providing immediate surge capacity to address emergency pandemic needs.

Duration: 3 years.

https://www.wellcomeleap.org/r3/